05.10.2018 23:45:00

Global Hypertension Market and Competitive Landscape 2014-2023

DUBLIN, Oct. 5, 2018 /PRNewswire/ --

The "Global Hypertension Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

Global Hypertension Market and Competitive Landscape - 2018, provides comprehensive insights into Hypertension pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Hypertension market size and drug sales. This research also provides insights into Hypertension epidemiology and late stage pipeline.

The research is classified into following sections - Hypertension overview with definitions, symptoms, etiology, diagnosis, treatment options; Hypertension pipeline insights covering late stage clinical trials pipeline; Hypertension prevalence trends by countries; Hypertension market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan.

Research Scope:

  • Hypertension pipeline: Find out the drugs in clinical trials for Hypertension by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Hypertension epidemiology: Find out the prevalence of Hypertension by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
  • Hypertension products: Identify key products marketed and prescribed for Hypertension by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Hypertension market size: Find out the market size for Hypertension drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
  • Hypertension drug sales: Find out the sales of Hypertension drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Hypertension drugs sales forecast: Sales forecast for Hypertension drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Hypertension market share analysis: Find out the market shares of Hypertension drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

Key Topics Covered:

1. Hypertension: Disease Overview
1.1. Hypertension Symptoms
1.2. Hypertension Etiology
1.3. Hypertension Diagnosis
1.4. Hypertension Treatment Options

2. Hypertension Pipeline Insights
2.1. Hypertension Phase 3 Clinical Trials
2.2. Hypertension Phase 2 Clinical Trials
2.3. Hypertension Phase 1 Clinical Trials

3. Hypertension Epidemiology Analysis

4. US Hypertension Market Insights

5. Germany Hypertension Market Insights

6. France Hypertension Market Insights

7. Italy Hypertension Market Insights

8. Spain Hypertension Market Insights

9. UK Hypertension Market Insights

10. Europe Hypertension Market Insights

11. Japan Hypertension Market Insights

12. Global Hypertension Market Insights

13. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/mdtg59/global?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-hypertension-market-and-competitive-landscape-2014-2023-300725257.html

SOURCE Research and Markets

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!